Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05838638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

StatusRecruiting
PhaseNot applicable
Started2023-06-09
View on ClinicalTrials.gov ↗

Amendment history

2026-04-27
Study Status v3
Re-verified, no change to tracked fields
2024-05-13
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2023-05-01→confirmed 2023-06-09
Study sites0→2
2023-05-03
Study Status, Outcome Measures v1
Secondary endpointsdetails revised at 2 of 4 entries
2023-04-20
Original filing
The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.
Trial Details
NCT Number NCT05838638
Lead Sponsor University of Central Florida
Collaborators: Orlando Health, Inc., University of Miami, National Institute of Nursing Research (NINR)
Conditions Neoplasms, Chemotherapy-induced Nausea and Vomiting
Enrollment 610 participants
Start Date 2023-06-09
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-01